O
Oliver Vonend
Researcher at University of Düsseldorf
Publications - 39
Citations - 1933
Oliver Vonend is an academic researcher from University of Düsseldorf. The author has contributed to research in topics: Primary aldosteronism & Blood pressure. The author has an hindex of 18, co-authored 37 publications receiving 1673 citations. Previous affiliations of Oliver Vonend include Ruhr University Bochum & University of Rostock.
Papers
More filters
Journal ArticleDOI
Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant Hypertension
Felix Mahfoud,Bodo Cremers,Julia Janker,Britta Link,Oliver Vonend,Christian Ukena,Dominik Linz,Roland E. Schmieder,Lars Christian Rump,Ingrid Kindermann,Paul A. Sobotka,Henry Krum,Bruno Scheller,Markus P. Schlaich,Ulrich Laufs,Michael Böhm +15 more
TL;DR: RD reduced blood pressure, renal resistive index, and incidence of albuminuria without adversely affecting glomerular filtration rate or renal artery structure within 6 months and appears to be a safe and effective therapeutic approach to lower blood pressure in patients with resistant hypertension.
Journal ArticleDOI
The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism.
Gian Paolo Rossi,Marlena Barisa,Bruno Allolio,Richard J. Auchus,Laurence Amar,Debbie L. Cohen,Christoph Degenhart,Jaap Deinum,Evelyn Fischer,Richard D. Gordon,Ralph Kickuth,Gregory A. Kline,André Lacroix,Steven B. Magill,Diego Miotto,Mitsuhide Naruse,Tetsuo Nishikawa,Masao Omura,Eduardo Pimenta,Pierre-François Plouin,Marcus Quinkler,Martin Reincke,Ermanno Rossi,Lars Christian Rump,Fumitoshi Satoh,Leo J. Schultze Kool,Teresa Maria Seccia,Michael Stowasser,Akiyo Tanabe,Scott O. Trerotola,Oliver Vonend,Jiri Widimsky,Kwan-Dun Wu,Vin-Cent Wu,Achille C. Pessina +34 more
TL;DR: Despite carrying a minimal risk of adrenal vein rupture and at variance with the guidelines, AVS is not used systematically at major referral centers worldwide, representing an argument for defining guidelines for this clinically important but technically demanding procedure.
Journal ArticleDOI
Adrenal Venous Sampling: Evaluation of the German Conn's Registry
Oliver Vonend,Nora Ockenfels,Xing Gao,Bruno Allolio,Katharina Lang,Knut Mai,Ivo Quack,Andreas Saleh,Christoph Degenhart,Jochen Seufert,Lysann Seiler,Felix Beuschlein,Marcus Quinkler,Petr Podrabsky,Martin Bidlingmaier,Reinhard Lorenz,Martin Reincke,Lars Christian Rump +17 more
TL;DR: Success rate in a retrospective analysis and comparison with procedures done prospectively after introduction of measures designed to improve rates of successful cannulation demonstrate the importance of throughput, expertise, and various potentially beneficial measures to improve adrenal vein sampling.
Journal ArticleDOI
International Expert Consensus Statement: Percutaneous Transluminal Renal Denervation for the Treatment of Resistant Hypertension
Markus P. Schlaich,Roland E. Schmieder,George L. Bakris,Peter J. Blankestijn,Michael Böhm,Vito M. Campese,Darrel P. Francis,Guido Grassi,Dagmara Hering,Richard E. Katholi,Sverre E. Kjeldsen,Henry Krum,Felix Mahfoud,Giuseppe Mancia,Franz H. Messerli,Krzysztof Narkiewicz,Gianfranco Parati,Krishna J. Rocha-Singh,Luis M. Ruilope,Lars Christian Rump,Domenic A. Sica,Paul A. Sobotka,Costas Tsioufis,Oliver Vonend,Michael A. Weber,Bryan Williams,Thomas Zeller,Murray D. Esler +27 more
TL;DR: Clinical trial data available thus far have been obtained primarily in patients with resistant hypertension, defined as standardized systolic clinic blood pressure ≥ 160 mm Hg despite appropriate pharmacologic treatment with at least 3 antihypertensive drugs, including a diuretic agent.
Journal ArticleDOI
Secondary rise in blood pressure after renal denervation
TL;DR: In July, 2011, a 58-year-old man with type II diabetes and hypertension resistant to treatment was referred to the hospital for renal denervation, where he had had hypertension for 30 years and his antihypertensive medication dose had been increased over several years.